GDF-15 (a biomarker for metformin) and the risk of COVID-19: A two-sample Mendelian randomization study
Description
CONCLUSIONS: Our study supports the notion that GDF-15 increases the risk of severe COVID-19 in patients. However, there is no causal relationship between GDF-15 and hospitalization or susceptibility to COVID-19.
